Walker BD - Search Results

1

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJ. Kiepiela P, et al. Among authors: walker bd. Nature. 2004 Dec 9;432(7018):769-75. doi: 10.1038/nature03113. Nature. 2004. PMID: 15592417

2

HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT. Walker BD, et al. Nature. 1987 Jul 23-29;328(6128):345-8. doi: 10.1038/328345a0. Nature. 1987. PMID: 3496541

3

Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.

Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI. Delwart EL, et al. Among authors: walker bd. J Virol. 1994 Oct;68(10):6672-83. doi: 10.1128/JVI.68.10.6672-6683.1994. J Virol. 1994. PMID: 8084001 Free PMC article.

4

Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexes.

Walter JB, Brander C, Mammen M, Garboczi DN, Kalams SA, Whitesides GM, Walker BD, Eisen HN. Walter JB, et al. Among authors: walker bd. Int Immunol. 1997 Mar;9(3):451-9. doi: 10.1093/intimm/9.3.451. Int Immunol. 1997. PMID: 9088983

5

Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

Cao H, Kanki P, Sankalé JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, Walker BD. Cao H, et al. Among authors: walker bd. J Virol. 1997 Nov;71(11):8615-23. doi: 10.1128/JVI.71.11.8615-8623.1997. J Virol. 1997. PMID: 9343219 Free PMC article.

6

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. Collins KL, et al. Among authors: walker bd. Nature. 1998 Jan 22;391(6665):397-401. doi: 10.1038/34929. Nature. 1998. PMID: 9450757

7

Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.

Brander C, Hartman KE, Trocha AK, Jones NG, Johnson RP, Korber B, Wentworth P, Buchbinder SP, Wolinsky S, Walker BD, Kalams SA. Brander C, et al. Among authors: walker bd. J Clin Invest. 1998 Jun 1;101(11):2559-66. doi: 10.1172/JCI2405. J Clin Invest. 1998. PMID: 9616227 Free PMC article.

8

Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection.

Brander C, Goulder PJ, Luzuriaga K, Yang OO, Hartman KE, Jones NG, Walker BD, Kalams SA. Brander C, et al. Among authors: walker bd. J Immunol. 1999 Apr 15;162(8):4796-800. J Immunol. 1999. PMID: 10202022

9

Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.

Kalams SA, Goulder PJ, Shea AK, Jones NG, Trocha AK, Ogg GS, Walker BD. Kalams SA, et al. Among authors: walker bd. J Virol. 1999 Aug;73(8):6721-8. doi: 10.1128/JVI.73.8.6721-6728.1999. J Virol. 1999. PMID: 10400770 Free PMC article.

10

T lymphocyte responses in HIV-1 infection: implications for vaccine development.

Brander C, Walker BD. Brander C, et al. Among authors: walker bd. Curr Opin Immunol. 1999 Aug;11(4):451-9. doi: 10.1016/S0952-7915(99)80076-4. Curr Opin Immunol. 1999. PMID: 10448136 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters